French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

Press releases published on September 16, 2026

Sep. 16, 2026

Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)

Indeterminate GlobeNewswire

Sep. 16, 2026

NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives

Indeterminate GlobeNewswire

Sep. 16, 2026

Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor

Indeterminate GlobeNewswire

Sep. 16, 2026

NeuroSigma Expands Payment Options for the Monarch eTNS® System

Indeterminate GlobeNewswire

Sep. 16, 2026

NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA

Indeterminate GlobeNewswire

Sep. 16, 2026

Propanc Biopharma Positions PRP’s EMT-Reversal Mechanism as a Complementary Backbone to Emerging RAS Inhibitors from Revolution Medicines, Inc. and Erasca, Inc.

Indeterminate GlobeNewswire

Sep. 16, 2026

Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum

Indeterminate GlobeNewswire

Sep. 16, 2026

Oragenics Chief Medical Officer to Present at IPAC-RS 2026 Nasal Innovation Forum

Indeterminate GlobeNewswire

Sep. 16, 2026

Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026

Indeterminate GlobeNewswire

Sep. 16, 2026

Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors

Indeterminate GlobeNewswire

Sep. 16, 2026

A.D.A.M. Innovations Expands GeneAI Forecast With New Chronic Disease Risk Assessment Models and Connected Biomarker Integration

Indeterminate GlobeNewswire

Sep. 16, 2026

DLH Secures Follow-On NHLBI IT Services Award Valued at Up to $43.7 Million

Indeterminate GlobeNewswire

Sep. 16, 2026

MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial

Indeterminate GlobeNewswire

Sep. 16, 2026

VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs

Indeterminate GlobeNewswire

Sep. 16, 2026

Philips-led projects win ITEA awards for advancing AI-enabled healthcare innovation

Indeterminate GlobeNewswire

Sep. 16, 2026

RIX Industries Partners with Build Health International to Bring Medical Oxygen Compressor Training to Africa

Indeterminate GlobeNewswire

Sep. 16, 2026

Teva Launches LongActingImpact.com to Advance Understanding of Earlier, Effective and Uninterrupted Schizophrenia Care

Indeterminate GlobeNewswire

Sep. 16, 2026

Rezera Announces Plans to Launch the REVEAL-PAD Multi-Center Study Investigating the Role of Inflammation in Patients with Peripheral Artery Disease

Indeterminate GlobeNewswire

Sep. 16, 2026

Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum

Indeterminate GlobeNewswire

Sep. 16, 2026

R1 Expands Phare OS with Phare UM, Bringing Real-Time Payer Risk Intelligence to Utilization Management

Indeterminate GlobeNewswire